REGENXBIO to Participate in Upcoming Investor Conferences

Rhea-AI Summary

REGENXBIO (Nasdaq: RGNX) has announced its participation in four major upcoming investor conferences in September 2025. The company will attend the Wells Fargo Healthcare Conference for one-on-one meetings in Boston on September 4, followed by three fireside chat presentations in New York: the Morgan Stanley Global Healthcare Conference on September 8, and both the Baird Global Healthcare Conference and H.C. Wainwright Global Investment Conference on September 9.

Select fireside chat presentations will be available via webcast through REGENXBIO's investor relations website, with recordings accessible for approximately 30 days after each event.

News Market Reaction

+2.15%

1 alert

+2.15% News Effect

On the day this news was published, RGNX gained 2.15%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ROCKVILLE, Md., Aug. 28, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:

2025 Wells Fargo Healthcare Conference
1x1 Investor Meetings: Thursday, September 4
Location: Boston, MA

Morgan Stanley 23^rd Annual Global Healthcare Conference
Fireside Chat: Monday, September 8, 2025 at 11:30 a.m. ET
Location: New York, NY

Baird 2025 Global Healthcare Conference
Fireside Chat: Tuesday, September 9, 2025 at 8:30 a.m. ET
Location: New York, NY

H.C. Wainwright 27^th Annual Global Investment Conference
Fireside Chat: Tuesday, September 9, 2025 at 2:30 p.m. ET
Location: New York, NY

Live webcasts of select fireside chats can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.

ABOUT REGENXBIO Inc.
REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku; and surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic retinopathy, in collaboration with AbbVie. Thousands of patients have been treated with REGENXBIO's AAV platform, including those receiving Novartis' ZOLGENSMA®. REGENXBIO's investigational gene therapies have the potential to change the way healthcare is delivered for millions of people. For more information, please visit WWW.REGENXBIO.COM.

Contacts:

Dana Cormack
Corporate Communications
dcormack@regenxbio.com 

Investors:
George E. MacDougall
Investor Relations
IR@regenxbio.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302540604.html

SOURCE REGENXBIO Inc.

FAQ

When is REGENXBIO (RGNX) presenting at the Morgan Stanley Healthcare Conference 2025?

REGENXBIO will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2025 at 11:30 a.m. ET in New York.

How can I watch REGENXBIO's (RGNX) investor conference presentations?

Select fireside chat presentations can be accessed through the Investors section of REGENXBIO's website at www.regenxbio.com, with replays available for approximately 30 days after each presentation.

Which investor conferences is REGENXBIO (RGNX) attending in September 2025?

REGENXBIO is attending four conferences: Wells Fargo Healthcare Conference (Sept 4), Morgan Stanley Global Healthcare Conference (Sept 8), Baird Global Healthcare Conference (Sept 9), and H.C. Wainwright Global Investment Conference (Sept 9).

Where will REGENXBIO's (RGNX) September 2025 investor conferences take place?

The Wells Fargo Healthcare Conference will be held in Boston, MA, while the Morgan Stanley, Baird, and H.C. Wainwright conferences will all take place in New York, NY.